OutSee

The company develops Nomaly, an AI engine that predicts disease and phenotypes directly from a single genome using fundamental molecular and cell biology rather than pattern-matching known associations. This technology identifies novel drug targets and uncovers biological mechanisms driving disease to support precision medicine. The platform enables patient stratification and works across both small and large datasets for common and rare diseases.